Inventor profile of:

Matthew SIEGEL

City:

Menlo Park, California

Country:

United States

Published Applications:

11

Last publication date:

2024-05-30

Top Assignees for applications by Matthew SIEGEL

The entities that hold a legal rights for patent applications filed by inventor SIEGEL Matthew:

Recent patent applications by SIEGEL Matthew

Matthew SIEGEL from Menlo Park, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-05-30
US20240174753A1
Chemistry; metallurgy

FUSION PROTEINS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS

#2 | 2023-11-02
US20230348549A1
Chemistry; metallurgy

CYTOKINE FUSION PROTEINS, AND THEIR PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC APPLICATIONS

#3 | 2022-06-23
US20220195021A1
Chemistry; metallurgy

ALBUMIN BINDING ANTIBODIES AND USE THEREOF

#4 | 2022-02-03
US20220033454A1
Chemistry; metallurgy

Interleukin-22 fusion proteins, and their pharmaceutical compositions

#5 | 2021-11-04
US20210340272A1
Chemistry; metallurgy

Anti-mesothelin constructs and uses thereof

#6 | 2021-11-04
US20210340208A1
Chemistry; metallurgy

Interleukin-2 polypeptides and fusion proteins thereof, and their pharmaceutical compositions and therapeutic applications

#7 | 2021-07-29
US20210230242A1
Chemistry; metallurgy

Cytokine-albumin binding moiety fusion proteins and uses thereof

#8 | 2021-06-03
US20210163565A1
Chemistry; metallurgy

Cytokine fusion proteins, and their pharmaceutical compositions and therapeutic applications

#9 | 2017-12-28
US20170368004A1
Human necessities

Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders

#10 | 2017-11-30
US20170340623A1
Human necessities

Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders

#11 | 2017-06-22
US20170174718A1
Chemistry; metallurgy

Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists

InventorID:

1908573 ⎘